BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

VANDA PHARMACEUTICALS INC

via MANATOS & MANATOS

3rd Quarter (July 1 - Sep 30) · 2024Posted Oct 15, 2024Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: VANDA PHARMACEUTICALS INC
Description: Pharmaceutical drug production
Location: District of Columbia · United States of America

Registrant

Firm: MANATOS & MANATOS
Description: Government affairs
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
FDA approval of specific medical drugs
Lobbyistsmr ANDREW EMANUEL MANATOS · mr MIKE ANDREW MANATOS
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

VANDA PHARMACEUTICALS INC — Lobbying — Receipts Report